RSV, or respiratory syncytial virus, is a common virus that causes cold symptoms. In particularly, young children and vulnerable older people are more likely to become seriously ill if they get it.

As a result of the coronavirus pandemic, new and additional disinfection methods have become available. Because not all of these products fall under the same legislation, there are some on the market today whose efficacy and safety have not been evaluated by an independent body.

Wastewater on aircraft from China has not been found to contain any new variants of the coronavirus SARS-CoV-2 so far. These findings are from several tests performed by RIVM. However, the wastewater was found to contain coronavirus particles.

People who worked from home during the COVID-19 pandemic were more likely to have physical complaints than people working on location (location workers). Examples included upper back pain, lower back pain, and pain in arms, neck and/or shoulders. These findings are from RIVM research.

COVID-19 vaccine uptake was lower in neighbourhoods that had proportionately higher percentages of residents from a non-Western migration background and residents who were more likely to vote for right-wing Christian and right-wing conservative political parties.

At the start of the autumn round, from mid-September 2022, the first group to be offered a repeat vaccination against COVID-19 was people with an elevated risk of a severe course of illness and care workers who have contact with patients and/or clients

RIVM advises government authorities to involve ‘key persons’ in formulating policy for current and future pandemics. Results from RIVM research show that these individuals played a key role in ensuring an ongoing focus on social well-being and mental health during the COVID-19 pandemic, despite the limitations.

Infections with the coronavirus SARS-CoV-2 are continuing to decrease in the Netherlands. This trend is also reflected in hospitals and nursing homes. The coronavirus thermometer is therefore shifting to status 1. The impact of SARS-CoV-2 on society and the healthcare system is currently limited.